The Swiss Connection
The Swiss Connection
SWI swissinfo.ch
Women’s Health Meets Drug Design and Medical Research
17 minutes Posted Nov 11, 2025 at 7:00 am.
Setting The Stage: Science Series
The Gender Gap In Drug Development
Lakembi’s Results Split By Sex
Why Differences May Exist
Regulators Weigh Benefits And Risks
Funding Shifts And Swiss Initiatives
From Male Mice To Human Bias
Clinical Trials And Who Gets Included
When Care Differs: Cardiac Case Study
Policy Progress In US And Europe
Switzerland’s Catch-Up And Reforms
Political Pushback And Corporate Responses
Changing Minds Inside Science
Wrap-Up And What’s Next
0:00
17:56
Download MP3
Show notes
Send us Fan Mail We trace how sex and gender shape drug development, from male-heavy mouse studies to the split results in Lecanemab’s Alzheimer’s trial. Experts explain why regulators should keep approvals moving while demanding smarter design, better reporting, and post-approval answers. For more science stories, visit our website swisinfo.ch, and you can help other people to find our podcast by leaving us a five-star review. Journalist: Jessica Davis Plüss Host: Jo Fahy Audio editor/vi...